{"related:2AmQ4hKm3vYJ:scholar.google.com/&scioq=counter-attack&hl=en&as_sdt=0,5":[{"title":"Fas counter-attack–the best form of tumor defense?","url":"https://www.nature.com/articles/nm0399_267","authors":["J O'Connell","J O'Connell MW Bennett","J O'Connell MW Bennett GC O'Sullivan","J O'Connell MW Bennett GC O'Sullivan JK Collins…"],"year":1999,"numCitations":82,"pdf":"https://www.researchgate.net/profile/Joe_OConnell/publication/13205464_Fas_counter-attack--the_best_form_of_tumor_defense/links/5552465408ae980ca606acd8/Fas-counter-attack--the-best-form-of-tumor-defense.pdf","citationUrl":"http://scholar.google.com/scholar?cites=17788838178200750552&as_sdt=2005&sciodt=0,5&hl=en&scioq=counter-attack","relatedUrl":"http://scholar.google.com/scholar?q=related:2AmQ4hKm3vYJ:scholar.google.com/&scioq=counter-attack&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=17788838178200750552&hl=en&as_sdt=0,5&scioq=counter-attack","publication":"nature.com","p":1,"exp":1596365388263},{"title":"Tumor counterattack–concept and reality","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/1521-4141(200003)30:3%3C725::AID-IMMU725%3E3.0.CO;2-D","authors":["FH Igney","FH Igney CK Behrens…"],"year":2000,"numCitations":95,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/1521-4141%28200003%2930%3A3%3C725%3A%3AAID-IMMU725%3E3.0.CO%3B2-D","citationUrl":"http://scholar.google.com/scholar?cites=6783503944818605907&as_sdt=2005&sciodt=0,5&hl=en&scioq=counter-attack","relatedUrl":"http://scholar.google.com/scholar?q=related:U79fs-XYI14J:scholar.google.com/&scioq=counter-attack&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=6783503944818605907&hl=en&as_sdt=0,5&scioq=counter-attack","publication":"Wiley Online Library"},{"title":"大肠上皮恶性转化不同阶段中 Fas/FasL 表达及在凋亡逃逸中的意义","url":"http://www.cqvip.com/qk/96407a/200303/8476032.html","authors":["王展宏， 孙保存， 赵秀兰， 王佩园， 刘易欣"],"year":2003,"numCitations":0,"relatedUrl":"http://scholar.google.com/scholar?q=related:KPPcqj-5m_QJ:scholar.google.com/&scioq=counter-attack&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=17625885249745253160&hl=en&as_sdt=0,5&scioq=counter-attack","publication":"cqvip.com"},{"title":"Immune escape in hepatocellular cancer: is a good offense the best defense?","url":"https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.510300232","authors":["T Patel"],"year":1999,"numCitations":15,"pdf":"https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.510300232","citationUrl":"http://scholar.google.com/scholar?cites=15904762110734839041&as_sdt=2005&sciodt=0,5&hl=en&scioq=counter-attack","relatedUrl":"http://scholar.google.com/scholar?q=related:AS1xZ98QudwJ:scholar.google.com/&scioq=counter-attack&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15904762110734839041&hl=en&as_sdt=0,5&scioq=counter-attack","publication":"Wiley Online Library"},{"title":"Fas and FasL expression at different stages of epithelial malignant transformation in the large intestine and it's significance in cancerous apoptotic evasion","url":"https://link.springer.com/content/pdf/10.1007/BF02761732.pdf","authors":["B Sun","B Sun X Zhao","B Sun X Zhao Z Wang","B Sun X Zhao Z Wang Y Liu","B Sun X Zhao Z Wang Y Liu H Qi","B Sun X Zhao Z Wang Y Liu H Qi X Cao"],"year":2004,"numCitations":0,"pdf":"http://cancerbiomed.org/index.php/cocr/article/viewFile/659/705","relatedUrl":"http://scholar.google.com/scholar?q=related:0AB1p32ASG8J:scholar.google.com/&scioq=counter-attack&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=8018800413701898448&hl=en&as_sdt=0,5&scioq=counter-attack","publication":"Springer"},{"title":"Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1096-9896(199811)186:3%3C240::AID-PATH173%3E3.0.CO;2-L","authors":["J O'Connell","J O'Connell MW Bennett","J O'Connell MW Bennett GC O'Sullivan…"],"year":1998,"numCitations":157,"citationUrl":"http://scholar.google.com/scholar?cites=16445405687852805743&as_sdt=2005&sciodt=0,5&hl=en&scioq=counter-attack","relatedUrl":"http://scholar.google.com/scholar?q=related:b66nc1fROeQJ:scholar.google.com/&scioq=counter-attack&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16445405687852805743&hl=en&as_sdt=0,5&scioq=counter-attack","publication":"Wiley Online Library"},{"title":"Predominant expression of Fas (CD95) ligand in metastatic melanoma revealed by longitudinal analysis","url":"https://www.sciencedirect.com/science/article/pii/S0022202X15405056","authors":["P Terheyden","P Terheyden C Siedel","P Terheyden C Siedel A Merkel","P Terheyden C Siedel A Merkel E Kämpgen…"],"year":1999,"numCitations":46,"pdf":"https://www.sciencedirect.com/science/article/pii/S0022202X15405056","citationUrl":"http://scholar.google.com/scholar?cites=3205611144710631758&as_sdt=2005&sciodt=0,5&hl=en&scioq=counter-attack","relatedUrl":"http://scholar.google.com/scholar?q=related:TrGCIFqefCwJ:scholar.google.com/&scioq=counter-attack&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3205611144710631758&hl=en&as_sdt=0,5&scioq=counter-attack","publication":"Elsevier"},{"title":"Human melanoma cells do not express Fas (Apo-1/CD95) ligand","url":"https://cancerres.aacrjournals.org/content/59/1/59.short","authors":["DB Chappell","DB Chappell TZ Zaks","DB Chappell TZ Zaks SA Rosenberg","DB Chappell TZ Zaks SA Rosenberg NP Restifo"],"year":1999,"numCitations":162,"pdf":"https://cancerres.aacrjournals.org/content/canres/59/1/59.full.pdf","citationUrl":"http://scholar.google.com/scholar?cites=4359220342068599243&as_sdt=2005&sciodt=0,5&hl=en&scioq=counter-attack","relatedUrl":"http://scholar.google.com/scholar?q=related:y9mnEs4PfzwJ:scholar.google.com/&scioq=counter-attack&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=4359220342068599243&hl=en&as_sdt=0,5&scioq=counter-attack","publication":"AACR"},{"title":"Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis","url":"https://clincancerres.aacrjournals.org/content/6/9/3560.short","authors":["K Okada","K Okada K Komuta","K Okada K Komuta S Hashimoto","K Okada K Komuta S Hashimoto S Matsuzaki…"],"year":2000,"numCitations":119,"pdf":"https://clincancerres.aacrjournals.org/content/clincanres/6/9/3560.full.pdf","citationUrl":"http://scholar.google.com/scholar?cites=4777957851546702571&as_sdt=2005&sciodt=0,5&hl=en&scioq=counter-attack","relatedUrl":"http://scholar.google.com/scholar?q=related:69I67Vm3TkIJ:scholar.google.com/&scioq=counter-attack&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=4777957851546702571&hl=en&as_sdt=0,5&scioq=counter-attack","publication":"AACR"},{"title":"Resistance to Fas (APO-1/CD95)-mediated apoptosis and expression of Fas ligand in esophageal cancer: the Fas counterattack","url":"https://academic.oup.com/dote/article-abstract/12/2/83/2419790","authors":["J O'connell","J O'connell MW Bennett","J O'connell MW Bennett GC O'sullivan…"],"year":1999,"numCitations":41,"citationUrl":"http://scholar.google.com/scholar?cites=11626340039839851950&as_sdt=2005&sciodt=0,5&hl=en&scioq=counter-attack","relatedUrl":"http://scholar.google.com/scholar?q=related:riWO0KoOWaEJ:scholar.google.com/&scioq=counter-attack&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=11626340039839851950&hl=en&as_sdt=0,5&scioq=counter-attack","publication":"academic.oup.com"}]}